BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25218248)

  • 1. [Prospective study of drug-induced interstitial nephritis in eleven French nephrology units].
    Leven C; Hudier L; Picard S; Longuet H; Lorcy N; Cam G; Boukerroucha Z; Dolley-Hitze T; Le Cacheux P; Halimi JM; Cornec Le Gall E; Hanrotel-Saliou C; Arreule A; Massad M; Duveau A; Couvrat-Desvergnes G; Renaudineau E
    Presse Med; 2014 Nov; 43(11):e369-76. PubMed ID: 25218248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Omeprazole-Associated Acute Interstitial Nephritis.
    Nypaver J; Nair D; Deshpande S; Amin S; Wynn J; Shrestha M; Pompella W
    Cureus; 2024 Feb; 16(2):e55035. PubMed ID: 38550437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute interstitial nephritis and hantavirus infection].
    Plappert D; Kraft L; Amann K; Latus J
    Dtsch Med Wochenschr; 2023 Nov; 148(23):1525-1535. PubMed ID: 37949081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone treatment in acute interstitial nephritis (PRAISE) - protocol for the randomized controlled trial.
    Mose FH; Birn H; Hoffmann-Petersen N; Bech JN
    BMC Nephrol; 2021 May; 22(1):161. PubMed ID: 33933012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune checkpoint inhibitors induce acute interstitial nephritis in mice with increased urinary MCP1 and PD-1 glomerular expression.
    Martinez Valenzuela L; Gómez-Preciado F; Guiteras J; Antón Pampols P; Gomà M; Fulladosa X; Cruzado JM; Torras J; Draibe J
    J Transl Med; 2024 May; 22(1):421. PubMed ID: 38702780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis.
    Moledina DG; Obeid W; Smith RN; Rosales I; Sise ME; Moeckel G; Kashgarian M; Kuperman M; Campbell KN; Lefferts S; Meliambro K; Bitzer M; Perazella MA; Luciano RL; Pober JS; Cantley LG; Colvin RB; Wilson FP; Parikh CR
    J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37395276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing Tides of Acute Interstitial Nephritis: A Retrospective Observational Study from South India.
    Shankar M; Gurusiddaiah SC; Mutalik S; Aralapuram K
    Indian J Nephrol; 2023; 33(5):362-365. PubMed ID: 37881735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing drug-induced AIN in the hospitalized patient: a challenge for the clinician.
    Perazella MA
    Clin Nephrol; 2014 Jun; 81(6):381-8. PubMed ID: 24691017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute interstitial nephritis in patients with inflammatory bowel disease treated with vedolizumab: a systematic review.
    Forss A; Flis P; Sotoodeh A; Kapraali M; Rosenborg S
    Scand J Gastroenterol; 2024 Apr; ():1-9. PubMed ID: 38682791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune checkpoint inhibitors and their interaction with proton pump inhibitors-related interstitial nephritis.
    Miao J; Herrmann SM
    Clin Kidney J; 2023 Nov; 16(11):1834-1844. PubMed ID: 37915905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unknown criminals for kidney: Acute interstitial nephritis due to lavender tea.
    Ozer H; Sayan ZA; Baloglu I; Ozturk Y; Yonet F; Turkmen K
    Explore (NY); 2023; 19(6):859-860. PubMed ID: 37394293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vedolizumab-induced acute interstitial nephritis with failure of steroid prophylaxis on vedolizumab rechallenge.
    O'Leary C; Wong D; Wilson G
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37699736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis, management, and outcomes of immune checkpoint inhibitor induced acute interstitial nephritis: A single-center experience.
    Elghawy O; Patel R; Barsouk A; Puthumana J; Xu J; Sussman J; Horton B; Kaur V
    J Oncol Pharm Pract; 2024 May; ():10781552241252627. PubMed ID: 38706192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience.
    Oleas D; Bolufer M; Agraz I; Felip E; Muñoz E; Gabaldón A; Bury R; Espinel E; Serón D; García-Carro C; Soler MJ
    Clin Kidney J; 2021 May; 14(5):1364-1370. PubMed ID: 34221369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune checkpoint inhibitors-induced nephropathy: a French national survey.
    Gérard AO; Andreani M; Fresse A; Parassol N; Muzzone M; Pinel S; Bourneau-Martin D; Borchiellini D; Rocher F; Esnault VLM; Drici MD;
    Cancer Immunol Immunother; 2021 Nov; 70(11):3357-3364. PubMed ID: 34155532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?
    Tan HZ; Sprangers B
    Clin Kidney J; 2023 Nov; 16(11):1709-1713. PubMed ID: 37915924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute interstitial nephritis with only three doses of pantoprazole.
    Samal S; Singhania N; Bansal S; Singhania G
    Clin Case Rep; 2020 Oct; 8(10):2084-2085. PubMed ID: 33088562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury.
    Praga M; Sevillano A; Auñón P; González E
    Nephrol Dial Transplant; 2015 Sep; 30(9):1472-9. PubMed ID: 25324356
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.